Core Nutritionals ZZZ 240g
Core Nutritionals ZZZ 240g
MSRP: $61.49
Our Price: $39.99

Product Code:

Choose your Flavor


Description Supplement Facts

Core Nutritionals ZZZ 240g

Night-Time Recovery and Sleep Support

You know the feeling: the weights feel heavy, the treadmill feels painfully slow, and every minute you’re looking up at the clock wondering when the workout is going to be over. Why? It’s not your diet – your food journal is so detailed it makes engineers blush. It’s not your supplementation – you are using the entire Core lineup like every smart trainer does. Ah, that’s right. Last night was a brutal mashup of tossing and turning set to the tune of your spouse’s snoring and the neighbor’s dog barking.

If recovery is the key to success, then say “hello” to the locksmith. Core ZZZ is a perfectly-designed product with a single goal in mind: maximizing your recovery. We have included only the best and most effective recovery agents, at the proper serving sizes, to take the guesswork out of a good night’s rest. We have also specifically chosen these ingredients for the pathways they target, ensuring that every possible physiological pathway for recovery is covered.

No more tossing nights and no more wasted workouts – put recovery at the top of your list by putting Core ZZZ at the center of your supplement lineup.

Scientific breakdown:

Mineral blend (Vitamin B-6 (as Pyridoxine HCL), Magnesium (as Magnesium aspartate), and Zinc (as Zinc monomethionine)):

Sleep is important, but sleep is not important for its own sake. Rather, we sleep because of the collection of physiological processes that it enables: the repair of tissue, the biosynthesis and release of hormones, and so on. While each of the individual ingredients in our mineral blend is important in this regard, the formulation as a whole has previously been demonstrated to have tangible physiological effects.

In a randomized, double-blind, placebo-controlled study, 27 NCAA football players consumed a supplement containing Vitamin B-6, Magnesium, and Zinc, or placebo, for an 8-week period. Measurements for free testosterone, IGF-1, and muscle strength and power were taken at the conclusion of the study. The authors found statistically significant increases to all measured indices, with a particularly high spike in free testosterone as compared to placebo.

Gamma-aminobutyric acid (GABA):

GABA, known technically as, γ-Aminobutyric acid, is a potent depressive and the chief inhibitory neurotransmitter in the human brain. As GABA plays a critical role in the sedative and depressive functions of the brain, GABA receptor subtypes – principally GABAA – have been positively associated with the regulation of the sleep-wake cycle.

Given its pivotal status in the regulation of sedation and sleep, both GABA itself as well as GABA agonists (GABAergics) have been researched for their capacity to modulate sleep and mood. A 1996 animal model study established that stimulation of the GABAA receptor-subtype through exogenous GABA intake led an increase in the length of slow-wave sleep. A further 2006 study found that increasing plasma levels of GABA through supplementation was associated with regulation of the posterior hypothalamus “sleep-wake switch,” a physiological mechanism used to control sleep in mammals.

In addition to GABA’s potential role in the regulation of sleep itself, additional research has uncovered that GABA may potentiate certain benefits of deep sleep – namely, the increase in plasma growth hormone. The first study to demonstrate GABA’s growth-hormone potentiating effect was a 1980 study in 19 healthy subjects. This placebo-controlled trial found that a 5 gram serving of GABA significantly increased plasma levels of growth hormone as compared to controls. A further study in 2008 demonstrated similar results, with 50% increases in plasma levels of certain growth hormone isoforms in response to GABA administration in healthy subjects.


Glycine is a non-essential amino acid, so-called because the human body is capable of synthesizing glycine from sources internal to the body (serine). Like many other amino acids, glycine possesses physiological effects independent of its function as a ‘building block’ to protein. In glycine’s case, its physiological effects stem from its role as a neurotransmitter in the human brain.

Three methodologically-sound studies have investigated glycine’s effect on sleep and sleep quality in humans – and each used the same serving size as that found in Core ZZZ, 3 grams. In studies conducted in 2006 and 2007, ingestion of 3 grams of glycine prior to sleep was found to have both subjective and objective positive effects on sleep. Subjectively, participants reported more satisfactory sleep, less daytime sleepiness, and improved cognitive function. Objectively, PSG measurements revealed less latency to sleep onset and deep sleep. These results were confirmed in a more recent 2012 study which focused principally on glycine-dependent improvements to daytime cognitive function in sleep-deprived volunteers.

Overall, these human trials suggest a possible role for glycine in the regulation of beneficial sleep cycles at a serving size of 3 grams.


Tryptophan is an essential amino acid, and one of the most critical in the human body. Tryptophan is critical because it is the biological precursor to both serotonin (one of the body’s principal neurotransmitters regulating mood, appetite, and sleep) and niacin (a vitamin and a crucial biological intermediate).

Among dietary supplements or ingredients purported to regulate the sleep-wake cycle, tryptophan is perhaps the most well-studied. The body of literature pertaining to tryptophan’s sedative effects is vast and varied, reaching back at least 40 years and featuring hundreds of articles. Despite the enormity of this body of literature, and therefore potential for disagreement or conflicting data, scientific consensus exists that tryptophan exerts positive effects on the regulation of the sleep wake cycle in humans – evinced by placebo-controlled trials in humans.

One such placebo-controlled, double-blind trial involved 10 healthy volunteers ingesting either 1.2 grams or 2.4 grams of tryptophan prior to sleep. Blood and urine measurements were taken at regular intervals, and sleep was measured both objectively (latency to sleep) and subjectively using the Stanford Sleepiness scale. Both serving sizes of tryptophan were highly correlated with a significant reduction in sleep latency and significant improvements to subjective sleep quality on the Stanford Sleepiness Scale.

Results such as this have been reproduced in dozens of clinical trials involving healthy/normal and sleep-disturbed subjects, men and women, younger and older participants, and featuring serving sizes as low as 500mg and high as 15 grams. These studies nearly universally reflect that exogenous tryptophan supplementation is positively correlated with an improvement in sleep quality and an objective reduction in sleep latency – with the best effects resultant from a 1 gram to 1.5 gram serving size.

Mucuna pruriens Extract (seed) (50% L-dopa):

Mucuna pruriens is a hanging or climbing plant endemic to India and sub-Saharan Africa. The plant has been used extensively in the Indian traditional medicinal system known as Ayurveda for a number of purposes, including virility and gastrointestinal disorders.

In the context of recovery, data is limited but promising. In a 2012 study, 18 healthy men and women with impaired sleeping were given a supplement containing Velvet Bean (MP) for 28 days. At the conclusion of the study, the participants completed the well-regarded and industry-standard Pittsburgh Quality Sleep Index.

The authors note that supplementation with the Velvet bean-containing product improved the reported scores in every category of the PQSI. Many categories saw improvements of over 50%. Moreover, the authors noted both that Velvet Bean, not the other ingredient in the studied supplement, was the bioactive compound responsible for these effects, and that Velvet Bean has been demonstrated to improve GH release during sleep in other independent trials.

Valerian Extract (Valeriana officinalis)(root)(1% valerenic acids):

Valeriana officinalis, more commonly known as Valerian Root, is a small perennial plant of the Valerianaceae genus and endemic to Southern Europe and Asia. Valerian root extracts, preparations, and tinctures have been used in a traditional medicinal capacity since at least the 2nd century for a wide variety of conditions, including anxiety, what would now be described as attention deficit hyperactive disorder, gastrointestinal disorders, and stress.

Research on valerian root suggests that it most likely promotes its sedative and sleep regulatory effects through direct stimulation of GABA biosynthesis, production, and release. In vitro studies have demonstrated multiple pathways by which valerian root increases GABA uptake or synthesis, including increasing the amount of GABA released into the synaptic cleft, preventing the reuptake of GABA into nerve cells, and inhibiting the action of an enzyme responsible for the bio-degradation of GABA.

A review of randomized, double-blind, placebo-controlled trials in humans suggests that valerian root’s GABA-increasing physiological actions may result in increased sleep quality. In a clinical trial comparing the sleep-improving effects of 10mg oxazepam to 600mg valerian root extract, 75 insomniacs ingested both compounds for 28 days. Subjects were assessed by a physician and were measured according to sleep quality and mood. At the conclusion of the trial, valerian root extract was found to have comparable effects to oxazepam with a lessened side effect profile.


Ornithine is a non-protein amino acid, meaning that, unlike most other amino acids, it is not involved in the production of proteins and is not encoded by DNA. In humans, ornithine is most commonly associated with the urea cycle, though recent research has revealed a potential role for ornithine in the regulation of sleep and arousal.

Though data on ornithine is not extensive, recent research has demonstrated that it may play a role in both objective and subjective assessments of sleep quality in humans. In a double-blind, placebo-controlled, randomized trial, 400mg or placebo was administered to 52 healthy adults experiencing mild fatigue. Ornithine was consumed consecutively for 8 weeks, with measurements for cortisol being collected – along with both subjective and objective measures of sleep quality.

At the conclusion of the trial, most participants experienced both subjective and objective improvements to the quality of their sleep. The researchers also noted that ornithine supplementation resulted in a small but statistically significant reduction to plasma concentrations of cortisol.


Melatonin is a hormone produced in the body by the pineal gland through a biosynthetic process beginning with tryptophan and ending with the conversion of serotonin to melatonin. Melatonin’s functions are regulated by a combination of norepinephrine and ultra-violet radiation. Once produced and released, melatonin helps control the body’s circadian rhythms and a number of other physiological processes.

As a dietary supplement, melatonin has been studied in a number of research populations with a wide-range of physiological conditions, as well as in healthy normal subjects. While studies in temporary behavioral modalities (jet lag, shift work) have proved inconclusive, clinical trials in populations with disturbed sleep had more promising results.

A 2004 review found that, while the intensity and specific effect depended on the population, melatonin generally improved either onset to sleep time or sleep efficiency. Onset to sleep is the time required before the participant has entered into unconscious sleep, while sleep efficiency is a measurement of the total time spent asleep in a given period.

This same review concluded that, while more research is necessary, melatonin is an intriguing possibility as an over-the-counter sleep facilitator.


Petroff OAGABA and glutamate in the human brain . Neuroscientist. (2002).

GABA in plasma and cerebrospinal fluid of different species. Effects of γ-acetylenic GABA, γ-vinyl GABA and sodium valproate.

Al-Sarraf H Transport of 14C-gamma-aminobutyric acid into brain, cerebrospinal fluid and choroid plexus in neonatal and adult rats . Brain Res Dev Brain Res. (2002).

Shyamaladevi N, et al Evidence that nitric oxide production increases gamma-amino butyric acid permeability of blood-brain barrier . Brain Res Bull. (2002).

Cavagnini F, et al. Effect of acute and repeated administration of gamma aminobutyric acid (GABA) on growth hormone and prolactin secretion in man . Acta Endocrinol (Copenh). (1980).

Cavagnini F, et al. Effect of gamma-aminobutyric acid on growth hormone and prolactin secretion in man: influence of pimozide and domperidone . J Clin Endocrinol Metab. (1980).

Powers ME, et al. Growth hormone isoform responses to GABA ingestion at rest and after exercise . Med Sci Sports Exerc. (2008).

Nindl BC, et al. Growth hormone molecular heterogeneity and exercise . Exerc Sport Sci Rev. (2003).

De Palo EF, et al. Growth hormone isoforms, segments/fragments: does a link exist with multifunctionality . Clin Chim Acta. (2006).

Kentaro INAGAWA et al. Subjective effects of glycine ingestion before bedtime on sleep quality. Sleep and Biological Rhythms. Volume 4, Issue 1, pages 75–77, February 2006

Wataru YAMADERA et al. Glycine ingestion improves subjective sleep quality in human volunteers, correlating with polysomnographic changes. Sleep and Biological Rhythms Volume 5, Issue 2, pages 126–131, April 2007

Bannai M, et al. The effects of glycine on subjective daytime performance in partially sleep-restricted healthy volunteers . Front Neurol. (2012).

Young SN (Sep 2013). "Acute tryptophan depletion in humans: a review of theoretical, practical and ethical aspects". Journal of Psychiatry & Neuroscience 38 (5): 294–305.

Young SN (2013). "The effect of raising and lowering tryptophan levels on human mood and social behaviour". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 368 (1615): 20110375.

"Information Paper on L-tryptophan and 5-hydroxy-L-tryptophan". FU. S. Food and Drug Administration, Center for Food Safety and Applied Nutrition, Office of Nutritional Products, Labeling, and Dietary Supplements. 2001-02-01.

Lapin P. Farmakol Toksikol. 1985 Jul-Aug;48(4):50-4. [Differences and similarity in the interaction of fenibut, baclofen and diazepam with phenylethylamine].

Stevinson C, Ernst E: Valerian for insomnia: a systematic review of randomized clinical trials. Sleep Medicine 1: 91-99, 2000.

Jadad AR, Moore RA, Carroll D, et al.: Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clinical Trials 17: 1-12, 1996.

Leathwood PD, Chauffard F, Heck E, Munoz-Box R: Aqueous extract of valerian root (Valeriana officinalis L.) improves sleep quality in man. Pharmacology, Biochemistry and Behavior 17: 65-71, 1982.

Leathwood PD, Chauffard F: Aqueous extract of valerian reduces latency to fall asleep in man. Planta Medica 2: 144-148, 1985.

Vorbach EU, Gortelmeyer R, Bruning J: Treatment of insomnia: effectiveness and tolerance of a valerian extract [in German]. Psychopharmakotherapie 3: 109-115, 1996.

Dorn M: Valerian versus oxazepam: efficacy and tolerability in nonorganic and nonpsychiatric insomniacs: a randomized, double-blind, clinical comparative study [in German]. Forschende Komplementärmedizin und Klassische Naturheilkunde 7: 79-84, 2000.

Donath F, Quispe S, Diefenbach K, Maurer A, Fietze I, Roots I: Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry 33: 47-53, 2000.

Russo EB: Valerian. In: Handbook of Psychotropic Herbs: A Scientific Analysis of Herbal Remedies in Psychiatric Conditions. Binghamton, NY: Haworth Press, 2001: 95-106.

Houghton PJ: The scientific basis for the reputed activity of valerian. Journal of Pharmacy and Pharmacology 51: 505-512, 1999.

Hendriks H, Bos R, Woerdenbag HJ, Koster AS. Central nervous depressant activity of valerenic acid in the mouse. Planta Medica 1: 28-31, 1985.

Brilla, L; Conte, V (October 2000). "Effects of a Novel Zinc-Magnesium Formulation on Hormones and Strength". Journal Of Exercise Physiology Online 3 (4): 26–36.

McCarthy CG, Alleman RJ, Bell ZW, Bloomer RJ. A Dietary Supplement Containing Chlorophytum Borivilianum and Velvet Bean Improves Sleep Quality in Men and Women. Integrative Medicine Insights. 2012;7:7-14.

Furek FW, Gillette MU (November 2004). "Melatonin, sleep, and circadian rhythms: rationale for development of specific melatonin agonists". Sleep Med. 5 (6): 523–32. doi:10.1016/j.sleep.2004.07.009. PMID 15511698.

Wade AG, Ford I, Crawford G, McMahon AD, Nir T, Laudon M, Zisapel N (October 2007). "Efficacy of prolonged release melatonin in insomnia patients aged 55–80 years: quality of sleep and next-day alertness outcomes". Curr Med Res Opin 23 (10): 2597–605.

Lemoine P, Zisapel N (2012). "Prolonged-release formulation of melatonin (Circadin) for the treatment of insomnia". Expert Opin Pharmacother 13 (6): 895–905.

Shamir E, Laudon M, Barak Y, Anis Y, Rotenberg V, Elizur A, Zisapel N (2000). "Melatonin improves sleep quality of patients with chronic schizophrenia". J Clin Psychiatry 61 (5): 373–7.

Dolberg OT, Hirschmann S, Grunhaus L (August 1998). "Melatonin for the treatment of sleep disturbances in major depressive disorder". Am J Psychiatry 155 (8): 1119–21.

Dalton EJ, Rotondi D, Levitan RD, Kennedy SH, Brown GM (2000). "Use of slow-release melatonin in treatment-resistant depression". J Psychiatry Neurosci 25 (1): 48–52.

Jan JE, Hamilton D, Seward N, Fast DK, Freeman RD, Laudon M (August 2000). "Clinical trials of controlled-release melatonin in children with sleep-wake cycle disorders". J. Pineal Res. 29 (1): 34–9.

De Leersnyder H, Bresson JL, de Blois MC, Souberbielle JC, Mogenet A, Delhotal-Landes B, Salefranque F, Munnich A (2003). "Beta 1-adrenergic antagonists and melatonin reset the clock and restore sleep in a circadian disorder, Smith-Magenis syndrome". J. Med. Genet. 40 (1): 74–8.

Cassone VM (November 1990). "Effects of melatonin on vertebrate circadian systems". Trends Neurosci. 13 (11): 457–64.

Lewy AJ, Sack RL, Miller LS, Hoban TM (January 1987). "Antidepressant and circadian phase-shifting effects of light". Science 235 (4786): 352–4.

Grossman E, Laudon M, Zisapel N (2011). "Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials". Vasc Health Risk Manag 7: 577–84.

Browse for more products in the same category as this item:

Shop By Brand > Core Nutritionals
Shop By Brand
Shop By Category > Nutrition & Sports Supplements
Shop By Category
New Arrivals
Shop By Category > Vitamins And Supplements > Sleep Aids
Recovery Supplements
Shop By Category > Vitamins And Supplements